The latest headlines across every section, pulled from official and open-access sources.
The U.S. Food and Drug Administration today granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic viral therapy for the treatment of advanced, refractory melanoma.
On August 6, 2026, the Food and Drug Administration granted accelerated approval to vusolimogene oderparepvec-wtpg (Tudriqev, Replimune, Inc.), a genetically modified oncolytic viral therapy, in combination with nivolumab for the treatment of adult patients with unresectable advanced cutaneous melan
Meet Hannah: Building a Beautiful Life with Type 1 Diabetes mseibold Thu, 08/06/2026 - 19:19 Type 1 Fitness Share Your Story By sharing your story, you help us raise awareness of diabetes so we can bend the curve on it once and for all. Will you help us awaken the world? Share Your Story
A culturally and medically tailored Indigenous Food is Medicine meal (CMTM) program reduced hospitalization and emergency department (ED) visits compared with dietary advice alone among patients with heart failure (HF) in Native communities, according to results of the MUTTON-HF trial, published July 27 in JAMA Internal Medicine.
The global burden attributable to elevated LDL-C has grown substantially since 1990, driven largely by population growth and aging despite significant declines in age-standardized rates, according to findings from the Global Burden of Disease Study 2023 (GBD 2023) Cholesterol Collaborators published July 29 in JAMA.
Each year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides the scientific and regulatory advice needed to bring safe, effective, high-quality generic alternatives to market, which in turn creates more affordable treatment options for pati
At MedCity News’ inaugural Bullseye conference in Chicago, Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed recent CMS actions and Mayo Clinic’s former research director, who has filed a complaint against the medical center over how it’s deploying AI. The post Debunked Episode 29: CMS GLP-1 Drug Pilot Program, RPM Strategy Raise Questions appeared first on MedCity News .
Data Descriptions updated (February 24, 2017)
This report describes emergency department visits involving cannabis hyperemesis syndrome (CHS) after implementing a CHS diagnosis code.
This report describes four poisoning deaths at an unlicensed ceremonial papermaking workshop in China.
CDC updates cyclosporiasis outbreak; avoid recalled iceberg lettuce and seek care if symptomatic.
As with any medicinal product, the MHRA will keep the safety and effectiveness of remibrutinib under close review.
Guidance and specifications for the recording and extraction of CTAD data from laboratories in England processing local authority and NHS commissioned chlamydia tests.
The Healthcare Goals programme brings together industry, academia, the third sector and the NHS to tackle healthcare challenges such as dementia, cancer, mental health, obesity and addiction.
The restructuring, intended to give Zimmer Biomet a fully dedicated sales force, is expected to be complete by the end of 2027.
Vaccines are safe, effective, and protect against influenza and other common illnesses PHILADELPHIA, August 6, 2026 – August is National Immunization Awareness Month, and the American College of Physicians (ACP) encourages adults to get vaccinated for protection against preventable diseases. Vaccines are critical tools for preventing deaths, hospitalizations, and the spread of disease, especially among those who are most vulnerable to serious complications. Keeping up to date with recommended vaccinations is essential for protecting both personal and public health. An…
The Drug Supply Chain Security Act (DSCSA) recognizes the role of small dispensers in the drug supply chain. Learn more.
FDA is issuing exemptions from certain requirements of section 582 of the FD&C Act to small business dispensers (e.g. pharmacies), and where applicable their trading partners, until November 27, 2027. This exemption allows time to complete the small dispensers assessment , publish the final assessme
The industry has made real progress in recognizing that oral health belongs at the center of whole-person care, but intent alone isn’t enough. To translate this vision into something tangible, the industry must invest in infrastructure that makes integration not only possible but scalable. The post Connecting the Dots: How Oral Health Can Enable Whole-Person Care appeared first on MedCity News .
Cold chain is a logistics problem — not just a throughput problem. Pharmacies must rethink their strategy, not just automate it. The post Should You Centralize Cold Chain Fulfillment? Only If You’ve Solved Distribution First appeared first on MedCity News .
FDA's annual Generic Drugs Forum is a two-day event designed to facilitate the development and approval of safe, effective, and high-quality generic medicines. Join us April 22-23, 2026.
The MHRA is providing an update on defects previously identified with Belzer solutions for the preservation of donated organs. This DSI replaces advice in DSI/2023/005.
Objectives Preoperative optimisation programmes aim to reduce complications after total joint arthroplasty (TJA), yet long-term effects on superficial surgical site infections (SSI), periprosthetic joint infections (PJI) and overall health remain unclear. This study evaluated the long-term impact of preoperative optimisation in cooperation with hospital and primary healthcare on infection outcomes and general health following elective primary lower extremity TJA. Design In this prospective quasi-experimental study, 1484 patients undergoing TJA were followed postoperatively. The intervention…
Objectives Guillain-Barré syndrome (GBS) is an autoimmune polyneuropathy manifested by progressive limb weakness. Anxiety and depression are significant yet under-recognised complications of GBS, particularly in low- and middle-income countries (LMICs). This study examined the proportion and progression of anxiety and depression in Bangladeshi GBS patients and their associations with clinical features, outcomes and quality of life (QoL). Design A prospective cohort study. Settings National Institute of Neurosciences and Hospital, Dhaka, Bangladesh. Participants A total of 148 GBS patients aged…